Jin Yang Pharmaceutical Co., Ltd. (KOSDAQ: 007370)
South Korea
· Delayed Price · Currency is KRW
5,550.00
+170.00 (3.16%)
Nov 15, 2024, 9:00 AM KST
Jin Yang Pharmaceutical Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Net Income | 9,807 | 12,659 | 12,308 | 9,538 | 5,229 | 1,647 | Upgrade
|
Depreciation & Amortization | 2,695 | 2,655 | 2,291 | 2,154 | 2,048 | 2,115 | Upgrade
|
Loss (Gain) From Sale of Assets | -0.87 | -0.86 | -24.9 | -9.53 | -0.6 | -7.67 | Upgrade
|
Asset Writedown & Restructuring Costs | -2,263 | -2,263 | -3,556 | -1,451 | -1,217 | - | Upgrade
|
Loss (Gain) From Sale of Investments | 113.74 | 9.65 | 97.96 | 13.48 | -762.1 | -828.12 | Upgrade
|
Provision & Write-off of Bad Debts | 1,843 | 1,470 | 50.09 | -1,383 | -2,635 | 13.45 | Upgrade
|
Other Operating Activities | -571.31 | 1,122 | 2,567 | 3,235 | 1,628 | 1,078 | Upgrade
|
Change in Accounts Receivable | 560.89 | -2,754 | -918.28 | 132.24 | 2,788 | 2,779 | Upgrade
|
Change in Inventory | 1,239 | -2,056 | -6,332 | -1,180 | -1,179 | 298.54 | Upgrade
|
Change in Accounts Payable | -3,010 | -756.94 | 2,227 | -1,827 | -620.7 | 536.53 | Upgrade
|
Change in Other Net Operating Assets | 2,191 | -1,551 | -1,263 | -7,251 | 966.43 | -421.77 | Upgrade
|
Operating Cash Flow | 12,599 | 8,534 | 7,448 | 1,971 | 6,245 | 7,209 | Upgrade
|
Operating Cash Flow Growth | 31.51% | 14.58% | 277.96% | -68.44% | -13.38% | 581.02% | Upgrade
|
Capital Expenditures | -16,371 | -682.28 | -3,218 | -2,516 | -1,363 | -736.71 | Upgrade
|
Sale of Property, Plant & Equipment | 0.91 | 0.91 | 25.09 | 9.55 | 6.36 | 69.36 | Upgrade
|
Sale (Purchase) of Intangibles | -184.73 | -851.25 | -1,423 | -207.08 | -8.33 | -15 | Upgrade
|
Investment in Securities | 5,290 | 4,775 | -7,950 | -1,528 | 3,042 | -969.44 | Upgrade
|
Other Investing Activities | -2.97 | -7 | -266.8 | -36.19 | -305 | 627.23 | Upgrade
|
Investing Cash Flow | -11,268 | 3,236 | -12,833 | -4,278 | 1,372 | -1,025 | Upgrade
|
Long-Term Debt Issued | - | - | - | 16,000 | - | - | Upgrade
|
Total Debt Issued | 8,740 | - | - | 16,000 | - | - | Upgrade
|
Short-Term Debt Repaid | - | - | - | -6,000 | -3,000 | -375.6 | Upgrade
|
Long-Term Debt Repaid | - | -5,678 | -189.12 | -129.92 | -135.03 | -3,065 | Upgrade
|
Total Debt Repaid | -7,514 | -5,678 | -189.12 | -6,130 | -3,135 | -3,441 | Upgrade
|
Net Debt Issued (Repaid) | 1,226 | -5,678 | -189.12 | 9,870 | -3,135 | -3,441 | Upgrade
|
Repurchase of Common Stock | - | - | -2,574 | - | - | - | Upgrade
|
Dividends Paid | -1,619 | -1,616 | -1,118 | -1,118 | -1,118 | -1,118 | Upgrade
|
Other Financing Activities | 0 | -110 | -1,700 | 100 | 100 | -0 | Upgrade
|
Financing Cash Flow | -392.82 | -7,404 | -5,581 | 8,852 | -4,153 | -4,559 | Upgrade
|
Foreign Exchange Rate Adjustments | 0.6 | -0.68 | - | - | - | -0.6 | Upgrade
|
Miscellaneous Cash Flow Adjustments | -0 | - | - | - | -0 | - | Upgrade
|
Net Cash Flow | 939.11 | 4,365 | -10,966 | 6,544 | 3,464 | 1,625 | Upgrade
|
Free Cash Flow | -3,772 | 7,851 | 4,230 | -545.86 | 4,881 | 6,472 | Upgrade
|
Free Cash Flow Growth | - | 85.62% | - | - | -24.58% | 785.18% | Upgrade
|
Free Cash Flow Margin | -3.64% | 8.34% | 5.55% | -0.87% | 9.86% | 13.67% | Upgrade
|
Free Cash Flow Per Share | -294.59 | 629.22 | 338.84 | -48.25 | 436.92 | 577.73 | Upgrade
|
Cash Interest Paid | 18.5 | 19.46 | 14.53 | 87.13 | 159.8 | 299.32 | Upgrade
|
Cash Income Tax Paid | 909.54 | 172.1 | 1,130 | 430.46 | 466.02 | 526.66 | Upgrade
|
Levered Free Cash Flow | -15,705 | 2,805 | -1,894 | -4,291 | 4,070 | 4,695 | Upgrade
|
Unlevered Free Cash Flow | -14,775 | 3,664 | -1,091 | -4,161 | 4,172 | 4,884 | Upgrade
|
Change in Net Working Capital | 4,996 | 3,136 | 5,702 | 7,943 | -833.24 | -3,656 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.